Adeno-associated virus (AAV) vectors in cancer gene therapy

Area of Science:

• Oncology
• Gene Therapy
• Molecular Biology

Background:

• Adeno-associated virus (AAV) vectors are established gene therapy tools with proven safety and efficacy in monogenic diseases.
• AAV vectors are increasingly explored for cancer treatment, with applications in preclinical models and early clinical trials.

Purpose of the Study:

• To review the use of AAV vectors in cancer models.
• To discuss advancements in AAV vector engineering and transgene design for cancer therapy.
• To outline the current clinical status and future prospects of AAV in oncology.

Main Methods:

• Literature review of AAV applications in cancer research.
• Analysis of vector engineering strategies for enhanced cancer cell transduction.
• Examination of payload design for targeted cancer gene therapy.
• Review of ongoing AAV clinical trials in oncology.

Main Results:

• AAV vectors have been successfully employed to deliver various transgenes in preclinical cancer models.
• Significant progress has been made in engineering AAV vectors for improved tumor targeting and transduction efficiency.
• Early clinical trials indicate potential for AAV-based therapies in certain cancer types.

Conclusions:

• AAV vectors represent a promising platform for gene therapy in oncology.
• Continued advancements in vector and payload design are crucial for optimizing AAV-based cancer treatments.
• Further clinical investigation is warranted to fully realize the therapeutic potential of AAV in cancer care.